<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am. J. Hum. Genet</journal-id>
      <journal-title-group>
        <journal-title>American Journal of Human Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0002-9297</issn>
      <issn pub-type="epub">1537-6605</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">30290153</article-id>
      <article-id pub-id-type="pmc">6174322</article-id>
      <article-id pub-id-type="publisher-id">S0002-9297(18)30316-1</article-id>
      <article-id pub-id-type="doi">10.1016/j.ajhg.2018.09.005</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Activating Mutations in <italic>PAK1,</italic> Encoding p21-Activated Kinase 1, Cause a Neurodevelopmental Disorder</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Harms</surname>
            <given-names>Frederike L.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kloth</surname>
            <given-names>Katja</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bley</surname>
            <given-names>Annette</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Denecke</surname>
            <given-names>Jonas</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santer</surname>
            <given-names>Ren&#xE9;</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lessel</surname>
            <given-names>Davor</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hempel</surname>
            <given-names>Maja</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff3" ref-type="fn">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kutsche</surname>
            <given-names>Kerstin</given-names>
          </name>
          <email>kkutsche@uke.de</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff3" ref-type="fn">3</xref>
          <xref rid="cor1" ref-type="corresp">&#x2217;</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany</aff>
      <aff id="aff2"><label>2</label>Department of Pediatrics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany</aff>
      <author-notes>
        <corresp id="cor1"><label>&#x2217;</label>Corresponding author <email>kkutsche@uke.de</email></corresp>
        <fn id="aff3">
          <label>3</label>
          <p id="ntpara0010">These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>04</day>
        <month>10</month>
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>04</day>
        <month>10</month>
        <year>2018</year>
      </pub-date>
      <volume>103</volume>
      <issue>4</issue>
      <fpage>579</fpage>
      <lpage>591</lpage>
      <history>
        <date date-type="received">
          <day>7</day>
          <month>6</month>
          <year>2018</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>9</month>
          <year>2018</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2018 American Society of Human Genetics.</copyright-statement>
        <copyright-year>2018</copyright-year>
        <copyright-holder>American Society of Human Genetics</copyright-holder>
      </permissions>
      <abstract id="abs0010">
        <p>p21-activated kinases (PAKs) are serine/threonine protein kinases acting as effectors of CDC42 and RAC, which are members of the RHO family of small GTPases. PAK1&#x2019;s kinase activity is autoinhibited by homodimerization, whereas CDC42 or RAC1 binding causes PAK1 activation by dimer dissociation. Major functions of the PAKs include actin cytoskeleton reorganization, for example regulation of the cellular protruding activity during cell spreading. We report the <italic>de novo PAK1</italic> mutations c.392A&gt;G (p.Tyr131Cys) and&#xA0;c.1286A&gt;G (p.Tyr429Cys) in two unrelated subjects with developmental delay, secondary macrocephaly, seizures, and ataxic gait. We identified enhanced phosphorylation of the PAK1 targets JNK and AKT in fibroblasts of one subject and of c-JUN in those of both subjects compared with control subjects. In fibroblasts of the two affected individuals, we observed a trend toward enhanced PAK1 kinase activity. By using co-immunoprecipitation and size-exclusion chromatography, we observed a significantly reduced dimerization for both PAK1 mutants compared with wild-type PAK1. These data demonstrate that the two <italic>PAK1</italic> variants function as activating alleles. In a cell spreading assay, subject-derived fibroblasts showed significant enrichment in cells occupied by filopodia. Interestingly, application of the PAK1 inhibitor FRAX486 completely reversed this cellular phenotype. Together, our data reveal that dominantly acting, gain-of-function <italic>PAK1</italic> mutations cause a neurodevelopmental phenotype with increased head circumference, possibly by a combined effect of defective homodimerization and enhanced kinase activity of PAK1. This condition, along with the developmental disorders associated with <italic>RAC1</italic> and <italic>CDC42</italic> missense mutations, highlight the importance of RHO GTPase members and effectors in neuronal development.</p>
      </abstract>
    </article-meta>
    <notes>
      <p id="misc0010">Published: October 4, 2018</p>
    </notes>
  </front>
</article>
</pmc-articleset>